Literature DB >> 6143950

Response to surfactant activator (ambroxol) in alveolar proteinosis.

J P Diaz, F Manresa Presas, C Benasco, J Guardiola, L Munoz, A Clariana.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6143950     DOI： 10.1016/s0140-6736(84)92370-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

Review 2.  Rare lung disease II: pulmonary alveolar proteinosis.

Authors:  Stephen C Juvet; David Hwang; Thomas K Waddell; Gregory P Downey
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

3.  Marked improvement in autoimmune pulmonary alveolar proteinosis with severe hypoxemia in a patient treated with ambroxol: a case report.

Authors:  Nao Oda; Koji Tamai; Yujiro Suzuki; Harukazu Yoshimatsu; Hirofumi Matsuoka; Yusuke Matsumoto; Nobuhiko Okada
Journal:  J Med Case Rep       Date:  2015-05-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.